Impact on Clinical. Status and Quality of Life of Switching From Regular Insulin to Insulin Lispro Among Patients Using Insulin Pumps
- 1 February 1998
- journal article
- research article
- Published by SAGE Publications in The Diabetes Educator
- Vol. 24 (1) , 95-99
- https://doi.org/10.1177/014572179802400113
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Strategies Toward Improved Control During Insulin Lispro Therapy in IDDM: Importance of basal insulinDiabetes Care, 1997
- Insulin LisproNew England Journal of Medicine, 1997
- Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapyDiabetes Care, 1997
- Insulin analoguesPostgraduate Medicine, 1997
- Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog TreatmentDiabetes, 1997
- Insulin Lispro: Its Role in the Treatment of Diabetes MellitusAnnals of Pharmacotherapy, 1996
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 1995
- Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDMDiabetologia, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 yearsJournal of Internal Medicine, 1991